SCHEMBL14770600

SCHEMBL14770600

c1ccc(-c2cc(-c3ccc4oc5ccc(-c6cncc(-n7c8ccccc8c8ccccc87)c6)cc5c4c3)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 2/20 0.37
KDM4E B2RXH2 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ATM Q13315 1/20 0.34
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
MAPK1 P28482 2/20 0.32
KMT2A Q03164 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
DHODH Q02127 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PLA2G10 O15496 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14770648 0.92 CYP19A1 (0.36) CYP19A1KDM4EL3MBTL1ATMPLA2G2A
SCHEMBL14770592 0.87 KDM4E (0.38) CYP19A1KDM4EL3MBTL1ATMPLA2G2A
SCHEMBL14733754 0.87 KDM4E (0.38) CYP19A1KDM4EL3MBTL1ATMPLA2G2A
SCHEMBL14770593 0.87 CASP3 (0.34) KDM4EL3MBTL1ATMPLA2G2APLA2G4A
SCHEMBL14770602 0.86 PLA2G2A (0.39) KDM4EL3MBTL1ATMPLA2G2APLA2G4A
SCHEMBL14770554 0.86 KDM4E (0.36) KDM4EL3MBTL1ATMPLA2G2APLA2G4A
SCHEMBL14770681 0.85 PLA2G2A (0.36) KDM4EL3MBTL1ATMPLA2G2APLA2G4A
SCHEMBL14770700 0.85 PLA2G2A (0.36) KDM4EL3MBTL1ATMPLA2G2APLA2G4A
SCHEMBL14770684 0.85 PLA2G2A (0.36) KDM4EL3MBTL1ATMPLA2G2APLA2G4A
SCHEMBL16185523 0.85 PLA2G2A (0.40) CYP19A1KDM4EL3MBTL1ATMPLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L CYP19A1 208/4885KDM4E 1763/4885L3MBTL1 3163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.